| Eliciting willingness to pay without bias: evidence from a field experiment K Blumenschein, GC Blomquist, M Johannesson, N Horn, P Freeman The Economic Journal 118 (525), 114-137, 2008 | 482 | 2008 |
| Hypothetical versus real willingness to pay in the health care sector: results from a field experiment K Blumenschein, M Johannesson, K Yokoyama, P Freeman Value in Health 4 (2), 79-79, 2001 | 303 | 2001 |
| Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma AJ Zillich, K Blumenschein, M Johannesson, P Freeman Pharmacoeconomics 20, 257-265, 2002 | 94 | 2002 |
| The changing landscape of naloxone availability in the United States, 2011–2017 PR Freeman, ER Hankosky, MR Lofwall, JC Talbert Drug and alcohol dependence 191, 361-364, 2018 | 92 | 2018 |
| Buprenorphine dispensing in an epicenter of the US opioid epidemic: a case study of the rural risk environment in Appalachian Kentucky HLF Cooper, DH Cloud, PR Freeman, M Fadanelli, T Green, C Van Meter, ... International Journal of Drug Policy 85, 102701, 2020 | 84 | 2020 |
| Association of naloxone coprescription laws with naloxone prescription dispensing in the United States M Sohn, JC Talbert, Z Huang, MR Lofwall, PR Freeman JAMA network open 2 (6), e196215-e196215, 2019 | 82 | 2019 |
| Pharmacists’ role in opioid overdose: Kentucky pharmacists’ willingness to participate in naloxone dispensing PR Freeman, A Goodin, SZ Troske, A Strahl, A Fallin, TC Green Journal of the American Pharmacists Association 57 (2), S28-S33, 2017 | 82 | 2017 |
| The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through … SL Walsh, N El-Bassel, RD Jackson, JH Samet, M Aggarwal, AP Aldridge, ... Drug and alcohol dependence 217, 108335, 2020 | 74 | 2020 |
| The opioid-overdose reduction continuum of care approach (ORCCA): evidence-based practices in the HEALing communities study T Winhusen, A Walley, LC Fanucchi, T Hunt, M Lyons, M Lofwall, ... Drug and alcohol dependence 217, 108325, 2020 | 65 | 2020 |
| Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings NJ Pauly, S Slavova, C Delcher, PR Freeman, J Talbert Drug and alcohol dependence 184, 26-32, 2018 | 64 | 2018 |
| Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists KM Alexander, HS Divine, CR Hanna, Y Gokun, PR Freeman Journal of the American Pharmacists Association 54 (5), 510-517, 2014 | 64 | 2014 |
| Trends and patterns of opioid analgesic prescribing: Regional and rural‐urban variations in Kentucky from 2012 to 2015 H Luu, S Slavova, PR Freeman, M Lofwall, S Browning, H Bush The Journal of Rural Health 35 (1), 97-107, 2019 | 57 | 2019 |
| Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study PR Freeman, GM Curran, KL Drummond, BC Martin, BS Teeter, K Bradley, ... Research in Social and Administrative Pharmacy 15 (6), 754-760, 2019 | 55 | 2019 |
| Community engagement to implement evidence-based practices in the HEALing communities study LS Martinez, BD Rapkin, A Young, B Freisthler, LS Glasgow, T Hunt, ... Drug and alcohol dependence 217, 108326, 2020 | 53 | 2020 |
| When prescribing isn't enough-pharmacy-level barriers to buprenorphine access HLF Cooper, DH Cloud, AM Young, PR Freeman The New England journal of medicine 383 (8), 703-705, 2020 | 52 | 2020 |
| Trends in gabapentin prescribing in a commercially insured US adult population, 2009-2016 NJ Pauly, C Delcher, S Slavova, E Lindahl, J Talbert, PR Freeman Journal of managed care & specialty pharmacy 26 (3), 246-252, 2020 | 49 | 2020 |
| Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist. LA Cassis, PE Rippetoe, EE Soltis, DJ Painter, R Fitz, MN Gillespie Journal of Pharmacology and Experimental Therapeutics 262 (3), 1168-1172, 1992 | 46 | 1992 |
| Consumer/patient encounters with prescription drug monitoring programs: evidence from a Medicaid population A Goodin, K Blumenschein, PR Freeman, J Talbert Pain physician 15 (3 Suppl), ES169, 2012 | 41 | 2012 |
| Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension. MN Gillespie, PE Rippetoe, CA Haven, RT Shiao, U Orlinska, BE Maley, ... American Journal of Respiratory and Critical Care Medicine 140 (5), 1463-1466, 1989 | 41 | 1989 |
| Smooth muscle actin and myosin expression in cultured airway smooth muscle cells JZ Wong, J Woodcock-Mitchell, J Mitchell, P Rippetoe, S White, M Absher, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 274 (5 …, 1998 | 39 | 1998 |
Jeffery TalbertProfessor and Division Chief, Biomedical Informatics, University of Kentucky在 uky.edu 的电子邮件经过验证
